The African Development Bank (AfDB), together with the Center for Disease Dynamics, Economics & Policy (CDDEP), the Commission on Investing in Health (CIH), The Bill & Melinda Gates Foundation (BMGF) and The Lancet invites you to the release of a report on investing in health and health financing titled "Global Health 2035: A World Converging within a Generation".

This report, released for the first time in Johannesburg, Tunis and London on December 3, 2012, "suggests investment framework to achieve dramatic health gains by 2035," said Agnes Soucat, Director of Human Development at the African Development Bank and member of the Commission on Investing in Health, who wrote the report.

What will tomorrow's health sector look like? To answer this question, the Commission on Investing in Health decided to revisit the since December 2012 the case for investing in health on the 20th anniversary of the World Bank's 1993 World Development Report (WDR 1993), Investing in Health. The Global Health 2035 report argues that healthier populations have better education outcomes and are more economically productive, and that well-chosen health expenditures are an investment in economic property and individual well-being rather than a drain on the economy.

The international multidisciplinary group of 25 Commissioners, is chaired by Lawrence H. Summers, President Emeritus, and Charles W. Eliot, University Professor, of Harvard University, and co-chaired by Dean T. Jamison, Professor at the University of Washington. The CIH has received support from the Bill & Melinda Gates Foundation, the Norwegian Agency for Development Cooperation (NORAD), the Harvard Global Health Institute (HGHI), the UK Department for International Development (DFID) and the BMGF-funded Disease Control Priorities Network (DCPN) project based at the Department of Global Health of the University of Washington.

The report includes an integrated global health investment plan for the period 2013-2035 and examines:

How the context for health investment has changed over the last 20 years;

The national policy opportunities for low- and middle-income countries to achieve dramatic health gains over the next 20 years and to reduce illness-related poverty;

The future role of international collective action for health, particularly in supporting research and development (R&D);

Controversial questions surrounding health care and health policy;

Innovative research, including estimations of burden of disease and the cost effectiveness of interventions.

View profiles of the 25 Commissioners.

Kindly confirm your participation by sending email.